Education
About Us
Working with TipRanks
Follow Us
Nektar Therapeutics (NKTR)
NASDAQ:NKTR
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 98.43M | $ 90.12M | $ 92.06M | $ 101.91M | $ 152.91M |
| Gross Profit | $ 67.74M | $ 53.48M | $ 70.42M | $ 77.01M | $ 133.44M |
| Operating Income | $ -105.20M | $ -137.43M | $ -240.24M | $ -446.10M | $ -379.92M |
| EBITDA | $ -86.70M | $ -243.11M | $ -323.87M | $ -461.82M | $ -394.33M |
| Net Income | $ -118.96M | $ -276.06M | $ -368.20M | $ -523.84M | $ -444.44M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 255.23M | $ 303.62M | $ 504.98M | $ 733.96M | $ 1.06B |
| Total Assets | $ 303.85M | $ 398.03M | $ 710.60M | $ 1.12B | $ 1.54B |
| Total Debt | $ 102.56M | $ 117.78M | $ 131.50M | $ 143.18M | $ 150.29M |
| Net Debt | $ 58.31M | $ 82.50M | $ 43.27M | $ 117.96M | $ -48.67M |
| Total Liabilities | $ 243.11M | $ 267.05M | $ 343.96M | $ 437.68M | $ 461.47M |
| Stockholders' Equity | $ 60.74M | $ 130.99M | $ 366.64M | $ 679.51M | $ 1.08B |
| Cash Flow | |||||
| Free Cash Flow | $ -177.18M | $ -193.47M | $ -309.68M | $ -427.65M | $ -320.55M |
| Operating Cash Flow | $ -175.71M | $ -192.61M | $ -304.01M | $ -412.66M | $ -313.29M |
| Investing Cash Flow | $ 142.57M | $ 139.56M | $ 365.83M | $ 202.78M | $ 496.21M |
| Financing Cash Flow | $ 42.12M | $ 30.00K | $ 1.51M | $ 36.24M | $ -80.35M |